ストックスクリーナーアプリを入手
1.79
1.65%
-0.03
アフターアワーズ：
1.78
-0.01
-0.56%
Actinium Pharmaceuticals Inc (ATNM) 最新ニュース
What institutions are buying Actinium Pharmaceuticals Inc. stock nowSuperior investment outcomes - jammulinksnews.com
What drives Actinium Pharmaceuticals Inc. stock priceAccelerated wealth expansion - PrintWeekIndia
Is Actinium Pharmaceuticals Inc. a good long term investmentRapid growth opportunities - Autocar Professional
What analysts say about Actinium Pharmaceuticals Inc. stockHigh-yield growth strategies - PrintWeekIndia
What analysts say about Actinium Pharmaceuticals Inc. stock outlookUnbelievable profit margins - jammulinksnews.com
Actinium Pharmaceuticals Inc. Stock Analysis and ForecastHigh-performance investment picks - jammulinksnews.com
Why Actinium Pharmaceuticals Inc. stock attracts strong analyst attentionCapital Protected Stock Selections - Newser
Lead Plaintiff Appointed in Actinium Pharmaceuticals Class Action - TradingView
Is Actinium Pharmaceuticals Inc. stock a growth or value playFree Access to Investment Community - beatles.ru
How Actinium Pharmaceuticals Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser
What makes Actinium Pharmaceuticals Inc. stock price move sharplyFree Investment Group - Newser
Actinium Highlights ATNM 400 Progress at SNMMI Conference - Yahoo.co
Actinium’s ATNM-400 demonstrates superior efficacy in prostate cancer - BioWorld MedTech
Positive Outlook on Actinium Pharmaceuticals: Promising Preclinical Data and Strong Financial Position Drive Buy Rating - TipRanks
Innovative Prostate Cancer Treatment ATNM-400 Shows Promising Pr - GuruFocus
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire
Investigation announced for Long-Term Investors in shares - openPR.com
Millennium Management LLC Has $148,000 Stake in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Kuehn Law Encourages Investors of Actinium Pharmaceuticals, Inc. to Contact Law Firm - PR Newswire
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Acquired by Squarepoint Ops LLC - Defense World
Nuveen Asset Management LLC Increases Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) Seeking Recovery for InvestorsContact The Gross Law Firm - mx.advfn.com
ATNM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Actinium Pharmaceuticals, Inc. to Contact the Firm Today! - ACCESS Newswire
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Shares Purchased by Deutsche Bank AG - Defense World
Northern Trust Corp Grows Stock Holdings in Actinium Pharmaceuticals, Inc. (NYSE:ATNM) - Defense World
Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM)May 27, 2025 Deadline to JoinContact Levi & Korsinsky - PR Newswire
Shareholders of Actinium Pharmaceuticals, Inc. (ATNM): Protect Your Rights Before May 27, 2025Contact Levi & Korsinsky - ACCESS Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Actinium - Business Wire
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
FINAL REMINDER ATNM DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Actinium Pharmaceuticals, Inc. Investors to Participate in the Class Action Lawsuit - ACCESS Newswire
2025-05-26 | Lost Money on Actinium Pharmaceuticals, Inc. (ATNM)? Urged to Join Class Action Before May 27, 2025Contact Levi & Korsinsky | NYSEAM:ATNM | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Actinium Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesATNM - Eastern Progress
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):